TMCnet News
electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumROCKAWAY, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, taking place on Wednesday, November 11, 2026, at The Westin New York Grand Central in New York City. Joshua Lev, Co-Chief Executive Officer, President and Chief Financial Officer, will present at the conference and host one-on-one meetings with investors throughout the day. Investors interested in scheduling a one-on-one meeting should contact their Canaccord Genuity sales reprsentative. About electroCore, Inc. For more information, visit www.electrocore.com. Contact:
|

